Curcumin ameliorates hippocampal neuron damage induced by human immunodeficiency virus-1

Neural Regeneration Research

Volumn 8, Issue 15, 2013, Pages 1368-1375

  Tang, Hong Mei ^a,b   Pan, Rui ^a   Fang, Wen Li ^a   Xing, Yan Yan ^a,b   Chen, De Xi ^c   Chen, Xiao Bao ^a   Yu, Yuan Yuan ^a   Wang, Jun Bing ^a,b   Gong, Zheng ^a,b   Xiong, Guo Yin ^a,b   Dong, Jun ^a,b  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Curcumin; Gp120 V3 loop; Grants supported paper; Human immunodeficiency virus 1 associated neurocognitive disorders; Neural regeneration; Neuroregeneration; Synapse; Traditional Chinese medicine

Indexed keywords

BETA ACTIN; CALCIUM; CURCUMIN; GLYCOPROTEIN GP 120; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN 2; NIMODIPINE; PROTEIN BAX; PROTEIN BCL 2; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CALCIUM HOMEOSTASIS; CELL STRUCTURE; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMAGING; IMMUNOFLUORESCENCE; MALE; MODULATION; NERVE CELL LESION; NERVE CELL PLASTICITY; NEUROPROTECTION; NEWBORN; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS REPLICATION; WHOLE CELL PATCH CLAMP;

EID: 84889795386     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2013.15.003     Document Type: Article

References (38)

1. Kaul M, Zheng J, Okamoto S, et al. HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ. 2005;12 Suppl 1:878-892.
2. Koutsilieri E, Scheller C, Sopper S, et al. The pathogenesis of HIV-induced dementia. Mech Ageing Dev. 2002;123(8):1047-1053.
3. Brito e Silva ET, Caixeta LF, Soares VL, et al. HIV-associated dementia in older adults: clinical and tomographic aspects. Int Psychogeriatr. 2011;23(7): 1061-1069.
4. McArthur JC. HIV dementia: an evolving disease. J Neuroimmunol. 2004;157(1-2):3-10.
5. Rumbaugh JA, Steiner J, Sacktor N, et al. Developing neuroprotective strategies for treatment of HIV-associated neurocognitive dysfunction. Futur HIV Ther. 2008;2(3): 271-280.
6. Gorry PR, Ong C, Thorpe J, et al. Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia. Curr HIV Res. 2003;1(4):463-473.
7. González-Scarano F, Martín-García J. The neuropathogenesis of AIDS. Nat Rev Immunol. 2005;5(1): 69-81.
8. + currents. PLoS One. 2011;6(10): e25994.
9. Xiong H, Zeng YC, Lewis T, et al. HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: relevance for HIV-1-associated dementia. J Neurovirol. 2000;6 Suppl 1:S14-23.
10. Merino JJ, Montes ML, Blanco A, et al. HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system. Rev Neurol. 2011;52(2):101-111.
11. Silverstein PS, Shah A, Weemhoff J, et al. HIV-1 gp120 and drugs of abuse: interactions in the central nervous system. Curr HIV Res. 2012;10(5):369-383.
12. Louboutin JP, Agrawal L, Reyes BA, et al. Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors. Gene Ther. 2007; 14(23):1650-1661.
13. Eugenin EA, King JE, Hazleton JE, et al. Differences in NMDA receptor expression during human development determine the response of neurons to HIV-tat-mediated neurotoxicity. Neurotox Res. 2011;19(1):138-148.
14. King JE, Eugenin EA, Hazleton JE, et al. Mechanisms of HIV-tat-induced phosphorylation of N-methyl-D-aspartate receptor subunit 2A in human primary neurons: implications for neuroAIDS pathogenesis. Am J Pathol. 2010;176(6):2819-2830.
15. Tang H, Lu D, Pan R, et al. Curcumin improves spatial memory impairment induced by human immunodeficiency virus type 1 glycoprotein 120 V3 loop peptide in rats. Life Sci. 2009;85(1-2):1-10.
16. Di Santo R, Costi R, Artico M, et al. Design, synthesis and biological evaluation of heteroaryl diketohexenoic and diketobutanoic acids as HIV-1 integrase inhibitors endowed with antiretroviral activity. Farmaco. 2005; 60(5): 409-417.
17. Shishodia S, Singh T, Chaturvedi MM. Modulation of transcription factors by curcumin. Adv Exp Med Biol. 2007; 595:127-148.
18. Sandur SK, Ichikawa H, Pandey MK, et al. Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic Biol Med. 2007;43(4):568-580.
19. Manikandan P, Sumitra M, Aishwarya S, et al. Curcumin modulates free radical quenching in myocardial ischaemia in rats. Int J Biochem Cell Biol. 2004;36(10):1967-1980.
20. Lin MS, Hung KS, Chiu WT, et al. Curcumin enhances neuronal survival in N-methyl-D-aspartic acid toxicity by inducing RANTES expression in astrocytes via PI-3K and MAPK signaling pathways. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(4):931-938.
21. Kuo CP, Lu CH, Wen LL, et al. Neuroprotective effect of curcumin in an experimental rat model of subarachnoid hemorrhage. Anesthesiology. 2011;115(6):1229-1238.
22. Creazzo TL, Burch J, Godt RE. Calcium buffering and excitation-contraction coupling in developing avian myocardium. Biophys J. 2004;86(2):966-977.
23. 2+ channels and GluN2B-containing NMDA receptors. J Neurosci. 2013; 33(2):624-630.
24. Clifford DB, Fagan AM, Holtzman DM, et al. CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology. 2009;73(23):1982-1987.
25. Zhao Y, Navia BA, Marra CM, et al. Memantine for AIDS dementia complex: open-label report of ACTG 301. HIV Clin Trials. 2010;11(1):59-67.
26. Perry SW, Barbieri J, Tong N, et al. Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax. J Neurosci. 2010;30(42):14153-14164.
27. Favors SE, Curd LM, Gregg RK. Use of the anti-inflammatory cytokine interleukin-11 to reverse HIV-1gp120 repression of a natural killer cell line. Cell Immunol. 2012;276(1-2):1-5.
28. Vajragupta O, Boonchoong P, Morris GM, et al. Active site binding modes of curcumin in HIV-1 protease and integrase. Bioorg Med Chem Lett. 2005;15(14): 3364-3368.
29. Tsai YM, Chien CF, Lin LC, et al. Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration. Int J Pharm. 2011;416(1): 331-338.
30. Ataie A, Sabetkasaei M, Haghparast A, et al. Neuroprotective effects of the polyphenolic antioxidant agent, Curcumin, against homocysteine-induced cognitive impairment and oxidative stress in the rat. Pharmacol Biochem Behav. 2010;96(4):378-385.
31. Gong Z, Yang LJ, Tang HM, et al. Protective effects of curcumin against human immunodeficiency virus 1 gp120 V3 loop-induced neuronal injury in rats. Neural Regen Res. 2012;7(3):171-175.
32. Wan QF, Nixon E, Heidelberger R. Regulation of presynaptic calcium in a mammalian synaptic terminal. J Neurophysiol. 2012;108(11):3059-3067.
33. Teles AV, Ureshino RP, Dorta DJ, et al. Bcl-x(L) inhibits Bax-induced alterations in mitochondrial respiration and calcium release. Neurosci Lett. 2008;442(2):96-99.
34. Clayton KB, Podlesniy P, Figueiro-Silva J, et al. NP1 regulates neuronal activity-dependent accumulation of BAX in mitochondria and mitochondrial dynamics. J Neurosci. 2012;32(4):1453-1466.
35. Pruunsild P, Sepp M, Orav E, et al. Identification of cis-elements and transcription factors regulating neuronal activity-dependent transcription of human BDNF gene. J Neurosci. 2011;31(9):3295-3308.
36. The Ministry of Science and Technology of the People's Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30.
37. Sánchez C, Díaz-Nido J, Avila J. Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function. Prog Neurobiol. 2000;61(2):133-168.
38. Chou P, Milne TJ. Real-time PCR focused-gene array profiling of gingival and periodontal ligament fibroblasts. Methods Mol Biol. 2010;666:373-383.